Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Teriparatide Compared With Risedronate on Back Pain in Postmenopausal Women With Osteoporotic Vertebral Fractures

NCT00343252 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00343252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00343252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Teriparatide Compared With Risedronate on Back Pain in Postmenopausal Women With Osteoporotic Vertebral Fractures
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2006
Completion date
June 30, 2010
Enrollment
712 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

back pain, osteoporosis, postmenopausal, spinal fracture